Karim Chamie, MD, presents the case of a 75-year-old woman with high-risk muscle invasive bladder cancer.
A 75-Year-Old Woman with High-Risk Muscle Invasive Bladder Cancer
Dr. Karim Chamie details the available primary and adjuvant treatments for muscle invasive bladder cancer.
An oncologist reviews the use of nivolumab in the adjuvant setting for treating high-risk muscle invasive bladder cancer and experience from his practice.
A bladder cancer expert several ongoing clinical trials in the neoadjuvant and adjuvant setting.
Karim Chamie, MD, describes what treatments might be on the horizon for muscle invasive bladder cancer and provides some clinical pearls to manage patients with MIBC.
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures
2
Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC
3
Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study
4
BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC
5
